Is 18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 3, 2010, Pages 269-274

  Shigekawa, Minoru ^a,b   Yamao, Kenji ^a   Sawaki, Akira ^a   Hara, Kazuo ^a   Takagi, Tadayuki ^a   Bhatia, Vikram ^c   Nishio, Masami ^d   Tamaki, Tsuneo ^e   El Amin, Hussein ^f   El Abdeen, Zain ^f   Sayed, Ahmed ^f   Mizuno, Nobumasa ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^d Nagoya PET Imaging Center   (Japan)

^e East Nagoya Imaging Diagnosis Center   (Japan)

^f ASSIUT UNIVERSITY   (Egypt)

Author keywords

Autoimmune pancreatitis; FDG PET; Pancreatic cancer; Steroid therapy

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; GLUCOCORTICOID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG UPTAKE; EYE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MALE; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; SALIVARY GLAND; AUTOIMMUNE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PANCREAS TUMOR; PANCREATITIS; RADIOGRAPHY; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77955887275     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0172-9     Document Type: Article

References (19)

1. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-8.
2. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409-18. (Pubitemid 351997877)
3. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613-25. (Pubitemid 44288524)
4. Ito T, Nakano I, Koyanagi S, Miyahara T, Migita Y, Ogoshi K, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42:1458-68.
5. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (in Japanese). J Jpn Pancreas society (Suizou) 2002;17:587.
6. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626-31. (Pubitemid 44288525)
7. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-6. (Pubitemid 44118845)
8. Kim MH, Kwon S. Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol. 2007;42(Suppl 18):42-9. (Pubitemid 46863937)
9. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med. 1999;40:1784-91. (Pubitemid 29523570)
10. Imdahl A, Nitzsche E, Krautmann F, Högerle S, Boos S, Einert A, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D- glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194-9. (Pubitemid 29090183)
11. Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)-usefulness and limitations in "clinical reality". Ann Nucl Med. 2003;17:261-79.
12. Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med. 2000;27:1835-8.
13. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007;34:2088-95. (Pubitemid 350212140)
14. Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi G, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum. 2005;53:298-303. (Pubitemid 40530173)
15. Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43:144-51. (Pubitemid 351344556)
16. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology. 1994;192:79-86. (Pubitemid 24191522)
17. Huang SC. Anatomy of SUV Standard uptake value. Nucl Med Biol. 2000;27:643-6.
18. Koyama K, Okamura T, Kawabe J, Nakata B, Chung KH, Ochi H, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med. 2001;15:217-24. (Pubitemid 32679215)
19. Nakamoto Y, Sakahara H, Higashi T, Saga T, Sato N, Okazaki K, et al. Autoimmune pancreatitis with F-18 fluoro-2-deoxy-D-glucose PET findings. Clin Nucl Med. 1999;24:778-80. (Pubitemid 29449634)